Scalp micro-needling: A new tool in the treatment of alopecia totalis
Clinical Dermatology Review, 2020 Alopecia areata is the most common form of nonscarring alopecia. It may vary from a single round patch to that involving large surface area termed as alopecia totalis (AT).
Savitha L Beergouder, Apoorva Reshme
doaj +1 more source
Alopecia totalis in a patient with Crohn's disease and its treatment with azathioprine. [PDF]
, 1989 A patient with Crohn's disease and alopecia totalis is described. Despite relative inactivity of the Crohn's disease, treatment with azathioprine was commenced. This led to complete regrowth of hair which was lost when the drug was discontinued.
P J Whorwell +5 more
core +3 more sources
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Antibodies against hair follicles are associated with alopecia totalis inautoimmune polyendocrine syndrome type I [PDF]
, 1999 In the autosomal recessively inherited autoimmune polyendocrine syndrome type I (APS I) patients have autoantibodies directed against several endocrine and nonendocrine organs.
Michaelsson, Gerd, +7 more
core +1 more source
Efficacy of Trichloroacetic Acid in Patients with Alopecia Areata: A Clinico-Histopathological Study [PDF]
International Journal of Medical Arts, 2023 Background: Alopecia areata is an autoimmune disorder caused by a breakdown in the follicular immune privilege system, resulting in non-scarring hair loss. Many therapeutic options have been tested with variable results.
Hossam Anter +3 more
doaj +1 more source
Alopecia totalis: Is treating nonresponder patients useful? [PDF]
, 1991 The purpose of this study was to assess the effectiveness of different treatments in patients with alopecia totalis or universalis who did not respond to sensitizing therapies.
Guerra, Liliana +2 more
core +1 more source
Direct Immunofluorescence Studies in Alopecia Areata and Male Pattern Alopecia [PDF]
, 1979 Direct immunofluorescence studies were performed on hairy and alopecic areas of scalp in patients with alopecia areata, alopecia totalis and male pattern alopecia.
Stengel, Fernando +2 more
core +1 more source
A Novel Hope for Alopecia Totalis Patients: Case Report [PDF]
, 2020 Alopecia areata (AA) is a common autoimmune disorder causing nonscarring patchy hair loss. Alopecia totalis (AT) is a severe variant of AA. Although there are several available treatment modalities for AA, efficacy of most of them is not satisfactory in ...
Afzalhussein Yusufali +3 more
core +1 more source
, 2020 Alopecia areata is a disease of multifactorial origin in which the presence of genetic, environmental and local autoimmune factors of the hair follicle intervenes that end up causing hair loss.
Rivas López, Pedro Javier
core +2 more sources
Successful treatment of alopecia totalis with tofacitinib in a Danish patient [PDF]
, 2021 Alopecia totalis (AT) is characterised by extensive hair loss on the scalp, and common treatments are rarely effective. Janus kinase inhibitors represent a potentially new treatment modality in AT.
Lottenburger, Tine, Lomborg, Niels
core +2 more sources